Evidence map›Paper›PMID 31213177›Full record

ArticleJournal of the Royal Society, Interface2019

The molecular chaperone Hsp33 is activated by atmospheric-pressure plasma protecting proteins from aggregation.

Marco Krewing, Jennifer Janina Stepanek, Claudia Cremers, Jan-Wilm Lackmann, Britta Schubert, Alexandra Müller, Peter Awakowicz, Lars I O Leichert, Ursula Jakob, Julia E Bandow

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer's disease.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Adhesion Properties ofMicroorganisms · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marco Krewing1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.
Jennifer Janina Stepanek1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.
Claudia Cremers4 Molecular, Cellular, and Developmental Biology, University of Michigan , Ann Arbor, MI , USA.
Jan-Wilm Lackmann1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.
Britta Schubert1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.
Alexandra Müller2 Microbial Biochemistry, Faculty of Medicine, Ruhr University Bochum , Bochum , Germany.
Peter Awakowicz3 Electrical Engineering and Plasma Technology, Faculty of Electrical Engineering and Information Sciences, Ruhr University Bochum , Bochum , Germany.
Lars I O Leichert2 Microbial Biochemistry, Faculty of Medicine, Ruhr University Bochum , Bochum , Germany.
Ursula Jakob4 Molecular, Cellular, and Developmental Biology, University of Michigan , Ann Arbor, MI , USA.
Julia E Bandow1 Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum , Bochum , Germany.

Funding

Role of Molecular Chaperones in Stress Response and DiseaseR35GM122506 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ursula H. Jakob · 2017 to 2026
$6.8M
Functional Analysis of the Intrinsically Disordered Chaperone Hsp33R01GM065318 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAKOB, URSULA H. · 2003 to 2015
$3.9M
NIGMS NIH HHS R01 GM065318NIGMS NIH HHS R35 GM122506
6 · The paper itself

Abstract

Non-equilibrium atmospheric-pressure plasmas are an alternative means to sterilize and disinfect. Plasma-mediated protein aggregation has been identified as one of the mechanisms responsible for the antibacterial features of plasma. Heat shock protein 33 (Hsp33) is a chaperone with holdase function that is activated when oxidative stress and unfolding conditions coincide. In its active form, it binds unfolded proteins and prevents their aggregation. Here we analyse the influence of plasma on the structure and function of Hsp33 of Escherichia coli using a dielectric barrier discharge plasma. While most other proteins studied so far were rapidly inactivated by atmospheric-pressure plasma, exposure to plasma activated Hsp33. Both, oxidation of cysteine residues and partial unfolding of Hsp33 were observed after plasma treatment. Plasma-mediated activation of Hsp33 was reversible by reducing agents, indicating that cysteine residues critical for regulation of Hsp33 activity were not irreversibly oxidized. However, the reduction yielded a protein that did not regain its original fold. Nevertheless, a second round of plasma treatment resulted again in a fully active protein that was unfolded to an even higher degree. These conformational states were not previously observed after chemical activation with HOCl. Thus, although we could detect the formation of HOCl in the liquid phase during plasma treatment, we conclude that other species must be involved in plasma activation of Hsp33. E. coli cells over-expressing the Hsp33-encoding gene hslO from a plasmid showed increased survival rates when treated with plasma while an hslO deletion mutant was hypersensitive emphasizing the importance of protein aggregation as an inactivation mechanism of plasma.

Indexed as

Protein AggregatesEscherichia coliEscherichia coli ProteinsHeat-Shock ProteinsOxidation-ReductionPlasma GasesEscherichia coli ProteinsHeat-Shock ProteinsHSP33 protein, E coliPlasma GasesProtein Aggregatesatmospheric-pressure plasmachaperonedielectric barrier dischargenon-equilibrium plasmaplasma resistance

Identifiers

PMID31213177
PMCPMC6597770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.